Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Change in Account Payables (2022 - 2023)

Historic Change in Account Payables for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $394000.0.

  • Lexeo Therapeutics' Change in Account Payables rose 13226.86% to $394000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$180000.0, marking a year-over-year change of. This contributed to the annual value of $2.4 million for FY2024, which is 142111.11% up from last year.
  • Latest data reveals that Lexeo Therapeutics reported Change in Account Payables of $394000.0 as of Q4 2023, which was up 13226.86% from $290000.0 recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' Change in Account Payables ranged from a high of $1.0 million in Q1 2023 and a low of -$1.9 million during Q2 2023